SG/PUT/DERMAPHARM HOLDING/40/0.1/21.06.24 Share Price

Warrant

DE000SU9HZD0

Market Closed - Boerse Frankfurt Warrants 20:36:50 17/05/2024 BST
0.29 EUR -12.12% Intraday chart for SG/PUT/DERMAPHARM HOLDING/40/0.1/21.06.24
Current month-63.75%
1 month-61.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/05/24 0.29 -12.12%
16/05/24 0.33 -13.16%
15/05/24 0.38 -19.15%
14/05/24 0.47 -7.84%
13/05/24 0.51 +4.08%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 08:36 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SU9HZD
ISINDE000SU9HZD0
Date issued 19/02/2024
Strike 40
Maturity 21/06/2024 (33 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.26
Delta0x
Omega 0.000000
Premium0x
Gearing12.47x
Moneyness 1.070
Difference Strike 2.6
Difference Strike %+6.50%
Spread 0.02
Spread %6.45%
Intrinsic value 0.2600
Present value 0.0400

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.4 EUR
Average target price
56.9 EUR
Spread / Average Target
+52.14%
Consensus